Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 207

1.

Antithrombotic therapy use at discharge and 1 year in patients with atrial fibrillation and acute stroke: results from the AVAIL Registry.

Lopes RD, Shah BR, Olson DM, Zhao X, Pan W, Bushnell CD, Peterson ED.

Stroke. 2011 Dec;42(12):3477-83. doi: 10.1161/STROKEAHA.111.625392. Epub 2011 Sep 8.

2.

Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation--a nationwide descriptive study in Taiwan.

Lin LJ, Cheng MH, Lee CH, Wung DC, Cheng CL, Kao Yang YH.

Clin Ther. 2008 Sep;30(9):1726-36. doi: 10.1016/j.clinthera.2008.09.010.

PMID:
18840379
3.

Cost-effectiveness of clopidogrel plus aspirin for stroke prevention in patients with atrial fibrillation in whom warfarin is unsuitable.

Coleman CI, Straznitskas AD, Sobieraj DM, Kluger J, Anglade MW.

Am J Cardiol. 2012 Apr 1;109(7):1020-5. doi: 10.1016/j.amjcard.2011.11.034. Epub 2012 Jan 3.

PMID:
22221944
4.

Safety and effectiveness of antithrombotic strategies in older adult patients with atrial fibrillation and non-ST elevation myocardial infarction.

Fosbol EL, Wang TY, Li S, Piccini JP, Lopes RD, Shah B, Mills RM, Klaskala W, Alexander KP, Thomas L, Roe MT, Peterson ED.

Am Heart J. 2012 Apr;163(4):720-8. doi: 10.1016/j.ahj.2012.01.017. Epub 2012 Mar 14.

PMID:
22520540
5.

Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials.

[No authors listed]

Arch Intern Med. 1994 Jul 11;154(13):1449-57. Erratum in: Arch Intern Med 1994 Oct 10;154(19):2254.

PMID:
8018000
6.

Atrial fibrillation and acute myocardial infarction: antithrombotic therapy and outcomes.

Lopes RD, Li L, Granger CB, Wang TY, Foody JM, Funk M, Peterson ED, Alexander KP.

Am J Med. 2012 Sep;125(9):897-905. doi: 10.1016/j.amjmed.2012.04.006. Epub 2012 Jul 13.

PMID:
22795814
7.

Newly detected atrial fibrillation and compliance with antithrombotic guidelines.

Glazer NL, Dublin S, Smith NL, French B, Jackson LA, Hrachovec JB, Siscovick DS, Psaty BM, Heckbert SR.

Arch Intern Med. 2007 Feb 12;167(3):246-52.

PMID:
17296879
8.

Status of antithrombotic therapy for patients with atrial fibrillation in university hospitals.

Albers GW, Yim JM, Belew KM, Bittar N, Hattemer CR, Phillips BG, Kemp S, Hall EA, Morton DJ, Vlasses PH.

Arch Intern Med. 1996 Nov 11;156(20):2311-6.

PMID:
8911237
9.

Relation of effective anticoagulation in patients with atrial fibrillation to stroke severity and survival (from the National Acute Stroke Israeli Survey [NASIS]).

Schwammenthal Y, Bornstein N, Schwammenthal E, Schwartz R, Goldbourt U, Tsabari R, Koton S, Grossman E, Tanne D.

Am J Cardiol. 2010 Feb 1;105(3):411-6. doi: 10.1016/j.amjcard.2009.09.050. Epub 2009 Dec 22.

PMID:
20102959
10.

Quality of care for atrial fibrillation among patients hospitalized for heart failure.

Piccini JP, Hernandez AF, Zhao X, Patel MR, Lewis WR, Peterson ED, Fonarow GC; Get With The Guidelines Steering Committee and Hospitals.

J Am Coll Cardiol. 2009 Sep 29;54(14):1280-9. doi: 10.1016/j.jacc.2009.04.091.

11.
13.

Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) Trial.

Reddy VY, Doshi SK, Sievert H, Buchbinder M, Neuzil P, Huber K, Halperin JL, Holmes D; PROTECT AF Investigators.

Circulation. 2013 Feb 12;127(6):720-9. doi: 10.1161/CIRCULATIONAHA.112.114389. Epub 2013 Jan 16.

14.

The effect and safety of the antithrombotic therapies in patients with atrial fibrillation and CHADS score 1.

Lee BH, Park JS, Park JH, Park JS, Kwak JJ, Hwang ES, Kim SK, Choi DH, Kim YH, Pak HN.

J Cardiovasc Electrophysiol. 2010 May;21(5):501-7. doi: 10.1111/j.1540-8167.2009.01661.x. Epub 2009 Dec 15.

PMID:
20021521
15.

Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

You JJ, Singer DE, Howard PA, Lane DA, Eckman MH, Fang MC, Hylek EM, Schulman S, Go AS, Hughes M, Spencer FA, Manning WJ, Halperin JL, Lip GY; American College of Chest Physicians.

Chest. 2012 Feb;141(2 Suppl):e531S-75S. doi: 10.1378/chest.11-2304.

16.

Warfarin use in nursing home residents: results from the 2004 national nursing home survey.

Ghaswalla PK, Harpe SE, Slattum PW.

Am J Geriatr Pharmacother. 2012 Feb;10(1):25-36.e2. doi: 10.1016/j.amjopharm.2011.12.001. Epub 2012 Jan 9.

PMID:
22226690
17.

Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.

Jacobs LG, Billett HH, Freeman K, Dinglas C, Jumaquio L.

Am J Geriatr Pharmacother. 2009 Jun;7(3):159-66. doi: 10.1016/j.amjopharm.2009.06.002.

PMID:
19616184
18.

Guidelines for stroke prevention in patients with atrial fibrillation.

Howard PA.

Drugs. 1999 Dec;58(6):997-1009. Review.

PMID:
10651387
19.

Time Trends of Aspirin and Warfarin Use on Stroke and Bleeding Events in Chinese Patients With New-Onset Atrial Fibrillation.

Guo Y, Wang H, Tian Y, Wang Y, Lip GY.

Chest. 2015 Jul;148(1):62-72. doi: 10.1378/chest.14-2018.

PMID:
25501045
20.

Cardioembolic vs. noncardioembolic strokes in atrial fibrillation: frequency and effect of antithrombotic agents in the stroke prevention in atrial fibrillation studies.

Hart RG, Pearce LA, Miller VT, Anderson DC, Rothrock JF, Albers GW, Nasco E.

Cerebrovasc Dis. 2000 Jan-Feb;10(1):39-43.

PMID:
10629345
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk